FEVASTIN
Main information
- Trade name:
- FEVASTIN 60ML SYR
- Active ingredient:
- Paracetamol
- Available from:
- TABLETS I.
- Dosage:
- 125MG/5ML
- Pharmaceutical form:
- SYR
- Composition:
- 60ML
- Medicine domain:
- Humans
- Medicine type:
- Allopathic drug
Documents
- for the general public:
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for the general public.
- for healthcare professionals:
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for healthcare professionals.
Localization
- Available in:
-
India
- Language:
- English
Other information
Status
- Source:
- Central Drugs Standard Control Organization
- Last update:
- 09-08-2016
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for the general public.
- Access to this document is only available to registered users.
Register now for full access
16-1-2018
Yunnan Feng Shi Ling capsules – counterfeit
Yunnan Feng Shi Ling capsules contain the undeclared substance paracetamol.
Therapeutic Goods Administration - Australia
27-2-2014
Paracetamol use during pregnancy
A new Danish study suggests a possible connection between mothers' use of paracetamol painkillers during pregnancy and the risk of developing disorders like ADHD (attention deficit hyperactivity disorder) in children.
Danish Medicines Agency
3-8-2012
Danish Pharmacovigilance Update, 21 June 2012
Among the topics covered in this issue of Danish Pharmacovigilance Update are: Decrease in the number of intoxications and suicide attempts using drugs containing acetylsalicylic acid or paracetamol.
Danish Medicines Agency
30-8-2018
Consultation: Referral of proposed amendment to the current Poisons Standard to the meeting of the ACMS, March 2019
Advisory Committee on Medicines Scheduling to consider upscheduling of modified release paracetamol to 'Pharmacist Only'. Closing date 31 October 2018
Therapeutic Goods Administration - Australia
30-8-2018
Modified release paracetamol
Advisory Committee on Medicines Scheduling to consider upscheduling of modified release paracetamol to 'Pharmacist Only'
Therapeutic Goods Administration - Australia